Technologically-Augmented Referrals to Mitigate Addiction Consequences

Completed · Not applicable

Conditions studied: Substance Use Disorders

In brief

The implementation of screening and intervention for substance use disorders, such as Screening Brief Intervention Referral to Treatment (SBIRT), in the primary care setting has faced several challenges. In the past, physicians have cited barriers such as lack of time, lack of access to treatment, and lack of financial resources. To overcome some of the barriers to screening and prevention of substance use disorders, many researchers have begun to explore novel approaches using web-based and mobile technology. While the quality of evidence is often inconsistent, there is promising research to show that interventions utilizing web-based or mobile technology for alcohol and other substance abuse can be effective. Features such as tailored feedback have shown to be more effective than similar programs without feedback, and interventions that combine self-administered therapy in conjunction with therapist-direction interventions show greater reductions in addictive behavior. In this project, the investigators proposed to enhance the Screening Brief Intervention Referral to Treatment (SBIRT) with a digital tool that aims to save physician time and improve patient adherence to treatment goals, through extensive use of shared decision making, patient self-monitoring and goal tracking, and real-time tailored patient feedback and text follow-up for patients. Increase the screening and referral of those patients at risk for substance use disorder (SUD) thereby increasing the number of patients receiving higher level substance use treatment. A total of 500 patients will be screened and randomized into two groups. 250 in the Technology Augmented Treatment group (intervention group) and 250 in the control group. The Washington State University research team, lead by Dr. McPherson, will screen and recruit subjects at CHAS Valley Clinic in Spokane, WA. Subjects in both groups will be followed up for 30 days. At the initial study enrollment visit, the intervention group will be asked questions on an iPad about their eligibility. After the initial visit, subjects in the intervention group will receive up to 4 texts/day on his/her phone that will ask questions about their health after the visit. The control group will be asked questions on an iPad and will be given a call 30 days after to ask questions about their health.

Key facts

Study ID

NCT04401215

Run by

Washington State University

People needed

9

Starts

2019-09-23

Expected to finish

2020-02-28

Last updated by the study team

2020-06-19

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants will be included if they:
• Do not answer "Never'' for TASP1 Q2 or Q3, Q4 \& Q5.
• Age 21 or older.
• Able to read and speak English.
• Able to provide written informed consent.
• Have access to a personal data enabled Mobile device for messaging.

You may not qualify if…

• Participants will be excluded if they meet one or more of the following criteria:
• Answer " "Never" for TAPS1 Q2 or Q3, Q4 \& Q5
• Currently in Substance abuse treatment.
• Have had previous substance use disorder (SUD) diagnosis less than a year ago.
• Were in a psychiatric hospital, or attempted suicide in the last 6 months.
• Have any other medical or psychiatric condition that the PIs determine would compromise safe study participation (e.g., terminal medical condition, recent myocardial infarction).
• Are pregnant.
• In the clinic for urgent conditions.

Where it is running

• CHAS Valley Clinic — Spokane Valley, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.